• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 43 of 100
Aimmune Peanut Allergy Treatment
Newsletters
A Pioneering Peanut Allergy Treatment on the Horizon: Brainstorm Health
By Sy MukherjeeSeptember 16, 2019
Amazon : Illustration
Tech
Amazon’s In-House Products Go Far Beyond AmazonBasics
By Alyssa NewcombSeptember 16, 2019
New York State Drew Up a Tax to Punish Opioid Makers—But Found Some Unanticipated Side Effects
Finance
New York State Drew Up a Tax to Punish Opioid Makers—But Found Some Unanticipated Side Effects
By Anastassia GliadkovskayaSeptember 16, 2019
A young girl holding up a nut and looking sad
Health
The FDA Is Weighing Final Approval on a Treatment for Peanut Allergies in Children and Teens
By Matthew Perrone and The Associated PressSeptember 13, 2019
Johns Hopkins Psychedelic Research Mushrooms
Newsletters
Johns Hopkins Launches a Pioneering Psychedelic Research Center: Brainstorm Health
By Sy MukherjeeSeptember 4, 2019
Vertex Semma Deal Stem Cells Diabetes
Newsletters
Vertex’s $950 Million Bet on Stem Cells to Cure Diabetes: Brainstorm Health
By Sy MukherjeeSeptember 3, 2019
FDA Cancer Drug Trials Placebo
Newsletters
FDA: Some Cancer Patients Shouldn’t Be Forced to Take Placebos in Drug Trials: Brainstorm Health
By Sy MukherjeeAugust 28, 2019
opioids
Health
Johnson & Johnson Helped Drive Oklahoma’s Opioid Crisis, Judge Rules
By Sean Murphy and The Associated PressAugust 26, 2019
FDA drug approvals Roche Celgene AbbVie
Newsletters
The FDA Went on an Epic Drug Approval Binge This Week: Brainstorm Health
By Sy MukherjeeAugust 16, 2019
Biotech bad day
Health
About Biopharma’s Ridiculously Bad Day: Brainstorm Health
By Sy MukherjeeAugust 8, 2019
fortune logo icon (red)
Commentary
Failure Is Built Into Pharma. But It’s Complicated: Brainstorm Health
By Sy MukherjeeAugust 2, 2019
Pharma drug development failure for business
Commentary
Pharma’s ‘Failure for Business’ Plan
By Mike Rea and Eneida PolloziAugust 2, 2019
Trump HHS drug reimportation
Health
Can Canada Help Fix America’s High Drug Price Problem?—Brainstorm Health
By Sy MukherjeeJuly 31, 2019
White pills lay on a white surface
Health
Trump Administration to Allow Americans to Get Cheaper Drugs from Canada
By Ricardo Alonso-Zaldivar and The Associated PressJuly 31, 2019
Humira AbbVie patents innovtation
Health
The Dark Side of the World’s Bestselling Drug: Brainstorm Health
By Sy MukherjeeJuly 18, 2019
1...
  • 41
  • 42
  • 43
  • 44
  • 45
...100
Most Popular
Cybersecurity
OpenAI says its AI models secretly broke out of a secure test environment and hacked into AI company Hugging Face in order to cheat on an evaluationplaceholder alt text
By Jeremy Kahn and Emily ForliniJuly 21, 2026
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
AI
Mathematicians grapple with a ‘very rapid and very unsettling change’ as AI cracks yet another century-old problemplaceholder alt text
By Eva RoytburgJuly 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.